28.01
price up icon5.38%   1.43
after-market Handel nachbörslich: 26.88 -1.13 -4.03%
loading
Schlusskurs vom Vortag:
$26.58
Offen:
$26.64
24-Stunden-Volumen:
94,084
Relative Volume:
3.31
Marktkapitalisierung:
$200.24M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.98M
KGV:
-21.26
EPS:
-1.3177
Netto-Cashflow:
$-3.85M
1W Leistung:
+7.32%
1M Leistung:
-1.09%
6M Leistung:
-31.87%
1J Leistung:
+2,446%
1-Tages-Spanne:
Value
$26.59
$28.82
1-Wochen-Bereich:
Value
$23.18
$28.82
52-Wochen-Spanne:
Value
$0.9305
$79.02

Bright Minds Biosciences Inc Stock (DRUG) Company Profile

Name
Firmenname
Bright Minds Biosciences Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
DRUG's Discussions on Twitter

Vergleichen Sie DRUG mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
DRUG
Bright Minds Biosciences Inc
28.01 200.24M 0 -4.98M -3.85M -1.3177
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Bright Minds Biosciences Inc Stock (DRUG) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-13 Eingeleitet TD Cowen Buy
2025-05-07 Eingeleitet Chardan Capital Markets Buy
2025-01-23 Eingeleitet Piper Sandler Overweight
2025-01-10 Eingeleitet Cantor Fitzgerald Overweight
2025-01-10 Eingeleitet H.C. Wainwright Buy
2024-11-26 Eingeleitet Robert W. Baird Outperform
Alle ansehen

Bright Minds Biosciences Inc Aktie (DRUG) Neueste Nachrichten

pulisher
Jun 16, 2025

4,793 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Acquired by Bank of America Corp DE - Defense World

Jun 16, 2025
pulisher
Jun 12, 2025

DRUG FY2025 EPS Forecast Raised by Cantor Fitzgerald - Defense World

Jun 12, 2025
pulisher
Jun 06, 2025

Bright Minds Biosciences (NASDAQ:DRUG) & SCYNEXIS (NASDAQ:SCYX) Head-To-Head Survey - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

6,600 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Acquired by Jane Street Group LLC - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

40,379 Shares in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Purchased by Millennium Management LLC - Defense World

Jun 04, 2025
pulisher
Jun 01, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of “Buy” from Analysts - Defense World

Jun 01, 2025
pulisher
May 28, 2025

(DRUG) Investment Analysis and Advice - news.stocktradersdaily.com

May 28, 2025
pulisher
May 28, 2025

Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 28, 2025
pulisher
May 28, 2025

Bright Minds Showcases Revolutionary CNS Drug Portfolio at Major Jefferies Healthcare Conference - Stock Titan

May 28, 2025
pulisher
May 26, 2025

HC Wainwright Issues Pessimistic Outlook for DRUG Earnings - Defense World

May 26, 2025
pulisher
May 26, 2025

What is Chardan Capital’s Forecast for DRUG FY2025 Earnings? - Defense World

May 26, 2025
pulisher
May 23, 2025

Chardan Capital Reiterates “Buy” Rating for Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

May 23, 2025
pulisher
May 21, 2025

Bright Minds Biosciences (DRUG) Receives Consistent 'Buy' Rating from Chardan Capital | DRUG Stock News - GuruFocus

May 21, 2025
pulisher
May 20, 2025

Bright Minds (DRUG) Schedules Virtual R&D Day to Discuss Epileps - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025 - The Manila Times

May 20, 2025
pulisher
May 20, 2025

Top Neurologists Reveal Latest Absence Epilepsy Breakthrough: Bright Minds Showcases Phase 2 Trial Progress - Stock Titan

May 20, 2025
pulisher
May 18, 2025

FY2025 Earnings Forecast for DRUG Issued By Chardan Capital - Defense World

May 18, 2025
pulisher
May 18, 2025

How To Trade (DRUG) - news.stocktradersdaily.com

May 18, 2025
pulisher
May 16, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Upgraded at Cantor Fitzgerald - Defense World

May 16, 2025
pulisher
May 14, 2025

Bright Minds Biosciences (DRUG) to Release Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 13, 2025

TD Cowen Initiates Coverage of Bright Minds Biosciences (DRUG) with Buy Recommendation - Nasdaq

May 13, 2025
pulisher
May 13, 2025

Bright Minds stock rating initiated with Buy at TD Cowen - Investing.com Australia

May 13, 2025
pulisher
May 13, 2025

TD Cowen Initiates Coverage on Bright Minds Biosciences (DRUG) w - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Bright Minds stock rating initiated with Buy at TD Cowen By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Bright Minds Biosciences Says BMB-101 Eliminated Drop Attacks in Mouse Model of Epilepsy - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Bright Minds (DRUG) Reports Promising Results in Epilepsy Research | DRUG Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Bright Minds reports BMB-101 eliminates drop attacks in mice By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101 - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Bright Minds (DRUG) Gains 'Buy' Rating from TD Cowen Analyst | D - GuruFocus

May 13, 2025
pulisher
May 10, 2025

Brokerages Set Bright Minds Biosciences Inc. (NASDAQ:DRUG) Target Price at $83.25 - Defense World

May 10, 2025
pulisher
May 10, 2025

Bright Minds Biosciences (NASDAQ:DRUG) Research Coverage Started at Chardan Capital - Defense World

May 10, 2025
pulisher
May 08, 2025

Chardan Capital Initiates a Buy Rating on Bright Minds Biosciences (DRUG) - The Globe and Mail

May 08, 2025
pulisher
May 07, 2025

Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside - Benzinga

May 07, 2025
pulisher
May 07, 2025

(DRUG) On The My Stocks Page - news.stocktradersdaily.com

May 07, 2025
pulisher
May 07, 2025

Chardan Capital Initiates Coverage of Bright Minds Biosciences (DRUG) with Buy Recommendation - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Chardan sets Bright Minds stock Buy rating, $80 target By Investing.com - Investing.com India

May 07, 2025
pulisher
May 07, 2025

Chardan sets Bright Minds stock Buy rating, $80 target - Investing.com

May 07, 2025
pulisher
May 01, 2025

Piper Sandler Reaffirms Their Buy Rating on Bright Minds Biosciences (DRUG) - The Globe and Mail

May 01, 2025
pulisher
Apr 28, 2025

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study - The Manila Times

Apr 28, 2025
pulisher
Apr 28, 2025

Major Epilepsy Breakthrough? Phase 2 Trial Results for Revolutionary Seizure Drug Coming May 20 - Stock Titan

Apr 28, 2025
pulisher
Apr 27, 2025

Piper Sandler sets $93 target for Bright Minds Biosciences stock - MSN

Apr 27, 2025
pulisher
Apr 22, 2025

Uncover the Best-Performing Canadian Biotech Stocks of 2025 - Investing News Network

Apr 22, 2025
pulisher
Apr 22, 2025

When (DRUG) Moves Investors should Listen - news.stocktradersdaily.com

Apr 22, 2025
pulisher
Apr 16, 2025

Bright Minds Biosciences: A Buy With A Major Catalyst In Q2 2025 (NASDAQ:DRUG) - Seeking Alpha

Apr 16, 2025
pulisher
Apr 03, 2025

Reviewing Allarity Therapeutics (NASDAQ:ALLR) & Bright Minds Biosciences (NASDAQ:DRUG) - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

Discover the Top 5 Small-Cap Biotech Stocks in 2025 - Investing News Network

Apr 01, 2025
pulisher
Mar 26, 2025

(DRUG) Trading Advice - news.stocktradersdaily.com

Mar 26, 2025
pulisher
Mar 21, 2025

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Sees Significant Decrease in Short Interest - Defense World

Mar 21, 2025
pulisher
Mar 18, 2025

DRUG FY2025 EPS Estimate Decreased by Cantor Fitzgerald - The AM Reporter

Mar 18, 2025
pulisher
Mar 18, 2025

Cantor Fitzgerald Has Weak Forecast for DRUG FY2025 Earnings - Defense World

Mar 18, 2025

Finanzdaten der Bright Minds Biosciences Inc-Aktie (DRUG)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Bright Minds Biosciences Inc-Aktie (DRUG) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Cormorant Asset Management, LP
10% Owner
Oct 15 '24
Buy
5.53
372,591
2,061,574
825,000
Cormorant Asset Management, LP
10% Owner
Oct 16 '24
Buy
23.46
50,000
1,172,813
875,000
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):